Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Up 28.9% in April

Avalon GloboCare Corp. (NASDAQ:ALBTGet Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 32,100 shares, a growth of 28.9% from the March 31st total of 24,900 shares. Currently, 5.0% of the shares of the company are short sold. Based on an average trading volume of 78,100 shares, the days-to-cover ratio is currently 0.4 days.

Avalon GloboCare Price Performance

NASDAQ ALBT opened at $3.85 on Friday. Avalon GloboCare has a 1-year low of $2.11 and a 1-year high of $21.60. The stock has a market capitalization of $6.36 million, a price-to-earnings ratio of -0.19 and a beta of 0.16. The business’s fifty day moving average price is $5.13 and its 200-day moving average price is $4.04.

Avalon GloboCare Company Profile

(Get Free Report)

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.

Read More

Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.